ABSTRACT Despite several studies both in vitro and in vivo, the pathogenesis of pulmonary fibrosis is unclear and some findings related to the biochemistry of collagen are controversial. Collagen metabolism was studied in 11 patients with idiopathic pulmonary fibrosis and in six control subjects. There was an increase in collagen concentration (mean 327 (SD 76) compared with control values of 185 (18) Mg/mg dry weight, p < 0.001), normal values for biosynthesis (mean 2.2% (0.8%) v 2.08% (0.5%), and a noteworthy decrease in collagenolytic activity (mean 0.07 (0.04) v 0.23 (0.04) pg of collagen degraded per mg of collagen incubated, p < 0.001). These results suggest that an alteration in enzymatic breakdown of collagen plays an important role in the maintenance and progression of interstitial fibrosis in this disease.
There has been renewed interest in the pathogenesis of diffuse interstitial pulmonary fibrosis in the last few years, with the publication of several studies in human subjects,I-5 and the development of many experimental models in various species using different agents. [6] [7] [8] [9] [10] Idiopathic pulmonary fibrosis (fibrosing alveolitis), a prototype of interstitial lung diseases, is characterised by interstitial and alveolar inflammation with considerable abnormalities in the pulmonary parenchyma. Although several morphological, biochemical, and immunological studies have been carried out with different techniques, the mechanisms responsible for the derangement of interstitial connective tissue, mainly collagen, and for the ultimate distortion of the normal lung architecture remain unknown.
To understand this complex problem better, we have studied simultaneously the concentration, biosynthesis, and degradation of collagen in lung tissue of patients with IPF and compared the results with those obtained from normal lung. After lung tissue had been dried to constant weight, aliquots were hydrolysed with 6N hydrochloride for 24 hours at 100°C, filtered, dried, and resuspended in distilled water. The hydroxyproline content was measured by two different colorimetric assays,"1 12 each in triplicate. No significant differences were found between the methods. The two techniques have similar principles. The samples were oxidised with chloramine T during 20 minutes at room temperature and then the reaction was stopped with 0.5 ml of 2 mol/l sodium thiosulphate1t or 1 ml perchloric acid.12 To convert the oxidation product of hydroxyproline to a pyrrol, the test tubes were placed in a strongly boiling water bath" or in 60°C water bath for 20 minutes.12 Basically, the difference between the two methods is the extraction with toluene recommended by Rojkind before the dimethylaminobenzaldehyde is added. Finally, the samples were read at 560-561 nm.
Methods
The amounts of collagen in the aliquots were calculated according to the formula 7.23 x hydroxyproline, on the assumption that this residue constitutes about 14% of the total of aminoacids in the a chain.'3 Collagen concentration was expressed as Mg per mg dry weight.
COLLAGEN BIOSYNTHESIS ASSAY
We used a modification of the assay described by Clark et al. 4 In brief, lung samples were divided into portions weighing about 100-200 mg (wet). These aliquots were then incubated in 3 ml of Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 50 pg/ml ascorbic acid, 70 pg/ml ferrous sulphate, 200 U/ml penicillin, and 200 ug/ml streptomycin. The cultures were equilibrated with 95% oxygen/5% carbon dioxide and incubated at 37°C in a shaking water bath. After one hour the medium was replaced with 3 ml of fresh medium with the above constituents and containing also 30 We used a modification of the method of Ryan and Woessner.'6 Tissue samples were homogenised with a polytron tissue homogeniser and the complete homogenate was divided into six aliquots, three of which were incubated in a metabolic shaker for 24 hours at 33°C in the presence of 0.005 mol/l calcium dichloride, 0.15 mol/l sodium chloride, and 0.04 mol/l tris buffer, pH 7.4. The remaining three aliquots were incubated under the same conditions but with 0.4 mol/l EDTA (collagenase inhibitor). So that we could be sure that the fragments obtained were smaller than an a chain of collagen (MW about 100 000 daltons) and represented objectively a product of degradation, the homogenates were centrifuged at 4°C and the supernatant was passed through a membrane that had an exclusion limit of 100 000 daltons (Diaflo XM-100, Amicon Corporation, Lexington, Massachusetts). Digestion was detected by the release of soluble hydroxyproline containing material. So that the ratio of active enzyme to substrate could be controlled the collagen content in the homogenate was measured and the coilagenolytic activity was expressed as pg of collagen degraded per mg of collagen incubated per hour. STATISTICAL 
METHODS
Results are expressed as means with standard deviations in parentheses. Comparisons between the study and control groups were made with Student's t test.
Results

COLLAGEN CONCENTRATION
The results of collagen concentrations in patients and controls are shown in figure 1. As has been previously shown,'7 18 there was a significant increase of collagen content in the lung tissue obtained from patients (mean 327 (76), compared with 185 (18) ug/mg dry weight in control lungs (p < 0.001)).
COLLAGEN SYNTHESIS BY SHORT-TERM LUNG EXPLANT CULTURES
Lung samples from both patients with idiopathic pulmonary fibrosis and control subjects actively incorporated [3H]proline into collagen [3H]hydroxyproline). The results obtained from both groups are shown in figure 2 ; no significant differences between them were recorded (2.2% (0.8%) v 2.08% (0.5%)). Unfortunately, these studies provide very few answers and raise many questions. Idiopathic pulmonary fibrosis is probably not a single disease; the term refers to complex pathological changes that may result from several unknown aetiological agents, resulting in subtle changes and modifications in the numbers of cells and the types and locations of lung cell populations and in endogenous mediators 358 responsible for the fibrotic response. The common feature, however, must be an imbalance in the normal homeostasis of the extracellular matrix (mainly collagen) so that synthesis exceeds breakdown, resulting in an excessive accumulation of this protein. In this regard, we studied collagen metabolism by simultaneously measuring biosynthesis and degradation. Possibly in the early stages of idiopathic pulmonary fibrosis there is an increase in collagen production along with inflammation, as has been observed in animal models.'42425 Our results, however, showed no increase in synthesis, perhaps because our patients were in a late stage of the disease. There are other possible reasons for this observation; if there were an increase of non-collagen proteins, the ratio of synthesis could be maintained with no apparent change even though collagen synthesis was increased, because the results are expressed as a percentage of synthesis of collagen in relation to synthesis of noncollagen proteins. Nevertheless, the incorporation of hydroxyproline per gram of tissue was the same for idiopathic pulmonary fibrosis and control lung. On the other hand, any in vitro study of synthesis has its limitations; the rates seem to be slower than those obtained in vivo26 and possibly the system is not sufficiently sensitive to detect differences. On the other hand, there was no correlation in the present study between collagen concentrations and rates of synthesis.
Our principal finding was a remarkable decrease of endogenous enzymatic breakdown of collagen in all the patients studied. By contrast, a previous report2" suggested that there is an increase of active collagenase in the lungs of patients with idiopathic pulmonary fibrosis but this study was carried out with bronchoalveolar fluid and exogenous type I collagen substrate, which may not reflect the interstitial events.
Collagen degradation has previously been studied in animal and human cirrhotic livers,28-30 and the results agree with ours. In the late stages of hepatic fibrosis collagenolytic activity decreases, and this also seems to occur in pulmonary fibrosis. Furthermore, a decrease or absence of degradation in the skin has been found in patients with scleroderma, a human disease characterised by an increase of collagen in the dermis and other organs.3'
Our results suggest that in patients with idiopathic pulmonary fibrosis in the fibrotic stage the persistence and progression of fibrosis is related to a decrease in degradation of collagen, which results in lack of collagen resorption and has in consequence an important effect on the rate of collagen turnover. The total amount of collagen present in lung parenchyma at a given moment will necessarily be the result of an equilibrium between collagen synthesis and collagen degradation and, although the former is normal in the Selman, Montafio, Ramos, Chapela more advanced or fibrotic stages, a diminution in the rate of collagenolytic activity may explain the abnormal deposition of this protein. Our findings clearly suggest that an alterated catabolic phase of the metabolic turnover of collagen plays an important part in the pathogenesis of idiopathic pulmonary fibrosis and probably other fibrotic disorders. Mammalian collagenases comprise several type specific hydrolytic enzymes,32-34 and collagenolysis is a complex process regulated by multiple pathways, including the susceptibility of the substrate in vivo.3S The key metabolic steps of collagen turnover need therefore to be studied in detail to determine how each is integrated in the overall physiological control mechanisms. 
